The Fallacy of Catching It in Time
The Obama administration is making a huge financial commitment to preventive care. But will it be targeted toward “early detection,” with its inherent risks, or will its focus be on true preventive care?
The Obama administration is making a huge financial commitment to preventive care. But will it be targeted toward “early detection,” with its inherent risks, or will its focus be on true preventive care?
A previous Pulse of Health Freedom issue mentioned the uncover operations of the Government Accountability Office (GAO) which ensnared Coast IRB, LLC, of Colorado Springs. The GAO created a fake medical study of a fake product to see whether for-profit review boards adequately supervised medical trials. Two firms turned it down but Coast IRB took […]
The Trilateral Cooperation Charter, or TCC, is an agreement signed in 2004 by Mexico, Canada, and the US. Its purpose is to increase communication, collaboration, and the exchange of information among the three countries in the areas of drugs, biologics, medical devices, food safety and nutrition—in theory, an exchange of “best practices.”
Several weeks back, Pulse of Health Freedom focused on the issue of electronic medical records, mentioning a Wall Street Journal opinion piece authored by two Harvard educators who disputed the administration’s claim that electronic medical records would save our healthcare system $80 billion.
Americans consume more medications than any other population on earth. And they’ve become increasingly aware that while medications are prescribed for certain benefits, the risks involved must be taken seriously. The economic stimulus legislation created a council of up to fifteen federal employees to coordinate the research and to advise Congress and the President how […]
In the not-too-distant past, the rate of autism in the US was listed as 1 in 10,000 children. It is now acknowledged to be 1 in 150 children and as high as 1 in 93 children in New Jersey. While there are those who point to better diagnosis as the reason for the increase, little […]
The Bravewell Collaborative, a philanthropic organization, partnered with the Institute of Medicine (IOM) to convene this past February’s Summit on Integrative Medicine and the Health of the Public. The primary goal is to make a shift in US healthcare. John Weeks, publisher and editor of The Integrator Blog, poses this question to the integrative medical […]
Two recent articles—one in the New York Times, the other in the Wall Street Journal—speak to a crisis of integrity in the medical industry that has led insiders like Dr. Jerome Kassirer of Yale and Tufts to muse that some of their colleagues appear to act as “paid prostitutes for the drug industry.”
The first nationwide study of human drugs in fish tissue is completed. Researchers found that fish caught near wastewater treatment plants serving five major US cities contained pharmaceutical residues, including medications used to treat high cholesterol, allergies, high blood pressure, bipolar disorder, and depression.
Two physicians once leaned over to me during a break in a live radio interview and whispered, “It’s the joke in medicine: Newer is not necessarily better, especially when it comes to drugs.” I was dumbfounded. New drugs had to be better, right?